Oxford Immunotec



Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology.  The company was founded in 2002 based on world-leading research at the University of Oxford.  The European headquarters are located in Abingdon, UK and the North American headquarters are located in Marlborough, MA USA.

T-Cell Xtend is an antibody complex directed against specific cell surface antigens
on human blood cells
• T-Cell Xtend cross-links selected white cells, that may interfere with ELISPOT
assays, with red blood cells
• This cross-linking increases the density of selected cells so that they form a pellet
when applied to a density gradient

The use of T-Cell Xtend allows the T-SPOT®.TB assay to be performed on blood samples up to 32 hours after venepuncture without any change in accuracy of the test.



1 Comment

August 29, 2013 · 4:25 pm

Kela Medical Inc.


Kela Medical Inc. harnesses the power of innovation and technology to pioneer leading-edge solutions, and demonstrate the value of a fully accessible personal health record to individuals, physicians, and practitioners of the healthcare industry.


Kela Medical Inc. introduces the pHR Card – Personal Health Record Card. The system uses patented* technology to provide economical solutions for physicians and patients to create, access, and maintain electronic medical records.


Kela Medical Inc. provides a healthcare IT service specifically designed for private medical practices. Our company is dedicated to delivering comprehensive solutions with the strength to make a difference in how you provide healthcare.


Leave a comment

August 29, 2013 · 1:26 pm



Sortable’s decision engine helps you make the right choice. Our engine powers niche markets to help visitors sort, compare and purchase consumer products.

Sortable is launching http://www.TabletRocket.com a tablet comparison website that makes it easier to research the best tablet by comparing tablet specs, performance tests, pricing info and reviews from around the web in one place. We’ve been working to replace the old tablets feature on Sortable with a new and improved site dedicated to tablets so enjoy!

Leave a comment

August 20, 2013 · 3:46 pm

abcam discoveries




Over the last 15 years, Abcam has remained committed to supporting scientists on their quest for discovery. We’ve focused on continually improving our high quality products and services by improving our global delivery times, enhancing our customer service offering, and increasing the validation information of our products. We’ve also expanded our product range beyond primary antibodies to include secondaries, proteins and peptides, lysates, biochemicals, immunoassays and other kits.

Leave a comment

August 15, 2013 · 5:09 pm




  1. MindFocus: Control your own digital environment. Switching the CanFocus light to red means 30 minutes of no distractions, and people will learn to leave you alone. You are digitally silenced, so you won’t be disturbed when you need to focus.
  2. MeetingFocus: The meeting organizer can silence his or her own digital device as well as the devices of those who have been invited to the meeting.
  3. ManagementFocus: Provides analytics on when you use the phone and how often, and when you work. It can help improve office layout, placing people based on the work they do to limit distractions and maximize corporate productivity.

Leave a comment

August 8, 2013 · 10:18 pm


affimiumAffinium is a specialty pharmaceutical company developing a new class of antibiotics that targets FabI in the bacterial fatty acid synthesis pathway AFN-1252, the lead clinical compound, is a first-in-class antibiotic for both oral and IV treatment of staphylococcal infections. AFN 1252 has highly potent activity only against staphylococci, including MRSA and all other drug resistant strains, and therefore may protect from off-target, negative effeccts of broader spectrum agents.

1 Comment

August 8, 2013 · 10:13 pm




Apollonia Health

Joon Kim founded Apollonia Health, an oral healthcare biotech company

Apollonia Health researches and develops innovative oral hygiene products that can safely and selectively eliminate cavity causing bacteria.


The company manufactures revolutionary oral healthcare products made only with naturally occurring ingredients. Because of this, their products can be used safely by children.


1 Comment

August 7, 2013 · 1:04 pm



Zyoxel develops and supplies cell culture platforms that support more physiologically relevant tissue models for pharmaceutical drug discovery applications:

  • Enabling the study of cellular behaviour and function in a more in vivo-like environment
  • Providing responses which closely replicate human clinical responses
  • Reducing the use of animals in testing
  • Reducing late stage clinical trial failures by identifying unsafe drugs and through selection of the most efficacious candidates earlier in development
  • Enabling more cost efficient drug development meaning that new medicines can be bought to market more quickly
Liver Chip enables cell culture in a 3D perfused state for advanced toxicity and efficacy testing

Liver Chip enables cell culture in a 3D perfused state for advanced toxicity and efficacy testing

Leave a comment

July 31, 2013 · 9:06 pm



Nexeon (www.nexeon.co.uk), is a unique silicon anode technology. Nexeon offers a significant step forward in lithium ion battery performance in a range of applications. the battery materials and licensing company, has signed a strategic partnership agreement with WACKER Chemie AG, and WACKER has taken a strategic stake in Nexeon.

Nexeon is developing silicon materials to replace carbon as the anode of lithium ion (Li-ion) batteries. This will lead to the production of rechargeable batteries with higher charge density, enabling consumers to use devices such as laptops and smart phones for longer before needing to recharge them. Stronger battery performance is also key to the wider adoption of electric and hybrid vehicles.
The partnership with Wacker will involve the two companies working together to scale-up the production of Nexeon’s silicon anode technology to commercial volumes. WACKER has strong research and chemical process capabilities as well as extensive production expertise in speciality materials and will be able to leverage its engineering and manufacturing expertise to accelerate Nexeon’s scale-up plans.


Leave a comment

July 30, 2013 · 8:30 pm

Ceres Power

Ceres Power (AIM:CWR, http://www.cerespower.com) is a developer of intermediate temperature solid oxide fuel cell technology. On 12th March the company announced its intention of raising  £9.7 million net through a placing to raise £8.7m and open offer to raise £1m, at 8 pence per share.
The proceeds of the fundraise are intended provide sufficient capital to take Ceres through the next stage of OEM engagements. Following the deployment of these funds, the Ceres core cell and FCM technology platform will be proven to be suitable for product development programmes with several OEMs in multiple geographies.
IP Group will invest £2 million in this round, and will thereafter hold 24.8% of Ceres’ enlarged issued share capital. Other investors in the round include existing shareholders ORA (Guernsey) Limited and Sarasin & Partners LLP, and new investor Henderson Global Investors Limited.


Leave a comment

July 30, 2013 · 8:08 pm


perasoPeraso Enables Next Generation Mobiles. Peraso’s 60 GHz ICs unlock 9 GHz of unlicensed spectrum in the 57-66GHz band, and thus acts as an enabling technology for a variety of new applications in the mobile realm.

In the mobile infrastructure market, 60 GHz is viewed as a primary technology choice for small cell backhaul. With features such as high bandwidth, narrow beamwidth and low latency, 60 GHz provides carriers with a viable, cost effective option to traditional backhaul methods such as fiber or microwave.

In mobile devices such as smartphones and tablets, 60 GHz provides a wireless alternative to existing wired standards like USB3.0 or HDMI. Peraso’s WiGig 60 GHz chipsets address this market with industry leading energy efficiency, a compact form factor, and sub-frame glass to glass latency.

Leave a comment

July 28, 2013 · 11:32 pm



FOTA : Dr. Tony Carusone at the Univ of Toronto has developed patent-pending breakthrough technology that both efficiently and affordably performs optoelectronic conversion for high-speed data signals within a tiny footprint.

Sustained data transfer rates equivalent to three parallel streams of high-definition video have been demonstrated in prototype components. Devices and customer evaluation boards are currently available for testing by qualified partners.

Dr. Carusone’s technology enables dramatic reductions in both cost and size while enabling significant performance improvements.


Read Introduction by MaRS: http://marsinnovation.com/company/fota-technologies/

1 Comment

July 28, 2013 · 10:28 pm


Prime Minister opens e-Therapeutics drug discovery centre

e-Therapeutics completes £40m placing e-Therapeutics plc (AIM: ETX, http://www.etherapeutics.co.uk), a spinout from Newcastle University, is a drug discovery and development company which is pioneering network pharmacology, a new approach to the discovery of medicines.
On 1st March, e-Therapeutics announced the completion of two share placings that raised £40 million in new equity (approximately £39 million net). The new shares were priced at 32p, a premium of 4% to the price on previous dealing day. Following the funding, the company has net cash and liquid resources of approximately £48 million, which together with expected receipts from R&D tax credits and interest, are intended to support all of its currently planned discovery and development activities into 2017, by which time an outlicensing deal for the company’s lead cancer drug ETS2101 should be in place.
As a result of the latest investment, Invesco Asset Management now holds 45.9% of the company’s shares, together with Henderson Global Investors (12.1%), Octopus Group (6.3%), Newcastle University (4.9%), and founder Professor Malcolm Young (14.9%), in all accounting for 84.1% of the company.

Leave a comment

July 28, 2013 · 9:42 pm



PathXL (www.pathxl.com), is the winner of 2012 Deloitte Technology Fast 50 – a spin-out from Queen’s University Belfast established in 2005, is a pioneer in the use of web-based solutions for digital pathology, mainly in regard to cancer. Its PathXL™ Manager product provides a web-based platform to enable digital pathology users across all fields to manage, view and collaborate around virtual slides easily and efficiently. In addition, PathXL provides a range of applications and workflows to deliver specific solutions to pathologists, scientists and students in education, research, clinical and biobanking settings. PathXL also provides a full range of supporting services, including scanning, hosting, image analysis and consultancy.

Leave a comment

July 28, 2013 · 9:26 pm

MiDaz Laser

Midaz Lasers Ltd

homepage8On 31st Oct 2012 Coherent Inc announced its acquisition of MiDAZ Lasers, a spinout from Imperial College London started in 2006, at the same time acquiring Innolight Innovative Laser and Systemtechnik GmbH. Coherent believes that together these companies provide core technology building blocks for an emerging class of commercial, low cost, subnanosecond pulsed lasers for micro-electronics manufacturing. The patented MiDAZ technology enables simple amplifiers to be incorporated in a broad range of laser products delivering power scaling and long lasting performance in electrically efficient designs.
Innolight manufactures low power, short pulse lasers for industrial applications like silicon processing, and ultra-stable continuous wave lasers used in demanding scientific applications like atom trapping.

Founded in 1966, Coherent Inc (Nasdaq:COHR http://www.Coherent.com) provides photonics based solutions to the commercial and scientific research markets.

MIDAZ ltd, Bessemer Bldg, Prince Consort Rd
London SW7 2AZ, United Kingdom

Year Founded:2006

Leave a comment

July 28, 2013 · 8:26 pm

CYP Design

De Montfort University (DMU) has joined forces with Ithaka Life Sciences to market new technology invented by Prof Bob Chaudhuri, which will provide new products and services based on a set of proteins, named cytochrome P450s (CYPs). CYPs are found in the human liver and are mostly responsible for the metabolism of drugs in people. These proteins are commercially available for use by firms involved in the discovery of new drugs, but are inconvenient to use as they must be transported and stored at temperatures as low as minus 80 degrees Celsius.
The new technology from DMU allows CYPs to be shipped and handled at room temperature, eliminating the need for a cold chain. This will reduce the cost and make their use in testing new drugs much quicker and easier.
DMU and Ithaka have established a new company called CYP Design Ltd (CDL). DMU has licensed the new technology to CDL which will now bring the new products to market. Ithaka has worked closely with Prof Chaudhuri to set up CDL and is leading the implementation of the business strategy through Dr Bill Primrose as CEO and Dr Paul Rodgers as chairman.


Leave a comment

July 28, 2013 · 8:18 pm


Keracol  ‘functional, natural, sustainable cosmetics’,  is a spin-out company from the University of Leeds, producing cosmetic products for hair coloration, hair care and skin care using novel approaches to the extraction, fractionation and purification of natural active molecules in the cleanest, most energy efficient way.
The company was founded by Dr Richard Blackburn, Senior Lecturer in Coloration Technology, and Prof Christopher Rayner, Head of Organic Chemistry, at the University of Leeds. Prof Rayner previously founded C-Capture, and he and Dr Blackburn together founded DyeCat, both spinouts from Leeds.

Keracol Leeds healthcare products & services 16-Aug-11 http://www.keracol.co.uk

Leave a comment

July 28, 2013 · 8:11 pm

Impression Technologies

Impression Technologies is an aluminium forming technology business based on intellectual property developed at Imperial College London.
The world’s automotive and transport industries will have to make a step change in their use of aluminium if they are to meet into complex shapes due to its limited ductility. Current technologies cannot meet the challenges faced in producing sophisticated shapes and structures for high volume applications cost effectively.
Prof Lin of Imperial College London and Dean of the University of Birmingham have developed the Hot Form Quench (HFQ) technology, which provides a cost-competitive means of producing lightweight, complex and structured aluminium components for the automotive, aerospace and rail industries.
In the patented HFQ process, an aluminium sheet is heated above its Solution Heat Treatment temperature, formed while hot, and quenched in the press. This process allows pressings to be formed which are lighter, deeper and with tighter radii than has been possible to date. The process is quicker and more costeffective than current methods, results in superior metallurgical properties, and allows stronger and lighter structures to be formed.
Impression Technologies is headed by CEO George Adam, an experienced automotive manager with over 30 years’ experience at GKN plc and ESAB China, and chairman Mike Foster, formerly CEO of Charter International plc, which he headed for five years following a career at GKN plc and Kvaener.http://www.impressiontech.ca/

Leave a comment

July 28, 2013 · 7:20 pm



Anacail was formed to commercialise technology developed at the Glasgow University’s School of Physics and Astronomy. The technology can rapidly and safely turn some of the oxygen inside packaged food into ozone, a very effective germicide. Plasma generated by a retractable device held briefly against the surface of plastic or glass packaging splits the bonds between oxygen molecules (O2) inside the packaging which then reform as ozone (or O3). The ozone naturally returns to its original state after just a couple of hours – more than enough time for any mould, fungi or bacteria on the packaging’s contents to be destroyed without adversely affecting its taste.
The product’s effectiveness as a germ-killer also extends food’s shelf-life by at least one extra day, and has been proven at UK labs including Campden BRI in Gloucestershire, where tests have shown an increase in shelf-life for products including bread and muffins, and a significant reduction of many pathogens in poultry including campylobacter, pseudomonas, and E.coli. The name Anacail means ‘shield’, ‘preserve’ or ‘protect’ in Gaelic.

1 Comment

July 28, 2013 · 7:03 pm



Brainomix developed a software that allows expertise of a world class stroke assessment team to be accessible by any doctor in an emergency department.
Brainomix is led by managing director Dr Michalis Papadakis, along with co-founders Professor Iris Grunwald and Professor Alastair Buchan, Professor of Stroke Medicine and Head of the Medical Sciences Division at the University of Oxford.

e-ASPECTS automates the Alberta Stroke Program Early CT Score (ASPECTS) pioneered by Prof Buchan. Over the last 12 years ASPECTS has been adopted worldwide. The original ASPECTS system relies on a scoring system to assess CT (X-ray computed tomography) scans but requires a stroke expert to gauge the images. The automated e-ASPECTS encapsulates the expertise of Prof Buchan and his team in software that processes CT images. The software gives a score that can be used by any doctor to assist in deciding on an intervention where there is only a four and a half hour window for treatment from the onset of the stroke.http://www.brainomix.com/

Brainomix was set up by Isis Innovation, the technology transfer arm of the University of Oxford, and developed with the support of the National Institute for Health Research Oxford Biomedical Research Centre.

Leave a comment

July 28, 2013 · 6:48 pm




Pavegen off-grid, interactive technology is highly engaging, bringing events and installations to life. Every time someone walks over a Pavegen tile, renewable energy is harvested from the footstep. The technology converts the kinetic energy to electricity which can be stored and used for a variety of applications. Pavegen worked with many of the world’s leading brands and organisations including Johnie Walker, WWF, Uniqlo, and Sainsbury’s helping to launch campaigns and ideas, powered by renewable energy.

West Ham station London Olympics, 2012

Central London Office installation

ur award-winning technology can play a vital role in helping our cities and communities achieve energy security and reduce emissions.

Unlike other renewable energy solutions, Pavegen is easy to understand and allows consumers to interact directly with the technology on-site or via the web.

Leading organisations and brands are demonstrating their commitment to a low-carbon future by installing Pavegen now and helping us to make the technology available to the wider community.

– See more at: http://www.pavegen.com/permanent#sthash.sxYkPLF8.dpuf

ur award-winning technology can play a vital role in helping our cities and communities achieve energy security and reduce emissions.

Unlike other renewable energy solutions, Pavegen is easy to understand and allows consumers to interact directly with the technology on-site or via the web.

Leading organisations and brands are demonstrating their commitment to a low-carbon future by installing Pavegen now and helping us to make the technology available to the wider community.

– See more at: http://www.pavegen.com/permanent#sthash.sxYkPLF8.dpuf

Our award-winning technology can play a vital role in helping our cities and communities achieve energy security and reduce emissions.

Unlike other renewable energy solutions, Pavegen is easy to understand and allows consumers to interact directly with the technology on-site or via the web.

Leading organisations and brands are demonstrating their commitment to a low-carbon future by installing Pavegen now and helping us to make the technology available to the wider community.

– See more at: http://www.pavegen.com/permanent#sthash.sxYkPLF8.dpuf

Our award-winning technology can play a vital role in helping our cities and communities achieve energy security and reduce emissions.

Unlike other renewable energy solutions, Pavegen is easy to understand and allows consumers to interact directly with the technology on-site or via the web.

Leading organisations and brands are demonstrating their commitment to a low-carbon future by installing Pavegen now and helping us to make the technology available to the wider community.

– See more at: http://www.pavegen.com/permanent#sthash.sxYkPLF8.dpuf

Leave a comment

July 23, 2013 · 6:32 pm

ISIS Software Incubator (ISI)


The Isis Software Incubator (ISI) supports nascent software ventures in the development of products or services and assists them to trade without external investment.

The ISI has been supporting such ventures since late 2010 and launched an on-site incubation facility at Summertown, Oxford in mid 2011.

The ISI is currently accepting applications from entrepreneurs interested in joining our programme.

If you’d like to apply, have any questions, or would like to get in touch for a different reason, don’t hesitate to contact:


Leave a comment

July 22, 2013 · 7:47 pm




SVX is a local, impact investing platform connecting impact ventures, funds, investors and service providers to mobilize private capital towards public good.

Leave a comment

July 19, 2013 · 1:45 pm


Canadian biotech company Qvella, headquartered in Toronto, is a molecular diagnostics company with new detection technology – preparing to bring a solution to the question of whether, and what, to prescribe when treating a possible infection is a problem.

If antibiotics are needed, they are most effective if used promptly – but the price of giving unnecessary treatment can be high, and includes not only the cost of the drugs themselves but also the growth of resistant strains of bacteria.

Currently, doctors can only get a definitive answer as to whether a patient is infected, and with what type of bacteria, after a sample from the patient is cultured in a lab, a process that takes between 24 and 72 hours. When a patient is in crisis, waiting that long simply isn’t an option. Sepsis, sometimes called a blood infection, is one such serious condition. It is the second cause of death among critical patients.



Leave a comment

July 17, 2013 · 5:15 pm


donor IQ

21 Century Fundraising Optimized

Increase your fundraising revenue by building personal relationships with all your donors – even the smallest ones.



July 10, 2013 · 6:47 pm

Encycle Therapeutics


MaRS Innovation and CQDM had jointly collaborated to form Encycle Therapeutics, a startup that was created around disruptive technology, developed by Prof Andrei Yudin of the University of Toronto, involving the cyclization of biologically active peptides. A year later, I’m pleased to report that Encycle is alive and kicking. The company has since recruited seasoned management, and its developing product line is drawing tremendous interest from global pharmaceutical groups.


Leave a comment

July 5, 2013 · 12:40 am




Aweekly online magazine that covers talent, innovation, diversity and quality of life stories in the Toronto region, covered Crowdmark‘s efforts to disrupt the way teachers grade and interact with students in their Innovation section on Wednesday, June 19, 2013.

Crowdmark graduated from the UTEST program earlier this spring. Last week, the company announced it has raised $600,000 in seed funding and completed two successful proof-of-concept pilot projects. Its co-founders are from the University of Toronto.


Leave a comment

July 5, 2013 · 12:07 am



Whirlscape Inc. released the beta version of its hotly anticipated, tiny, one-dimensional digital keyboard, Minuum: “the little keyboard for big fingers.”

If you follow tech gadget news, you’ve likely read about or even supported the company’s successful Indiegogo campaign, which raised more than US$87,000—over 870% above their modest initial goal of $10,000—from nearly 10,000 supporters who have now become beta users for the product.

The stats don’t end there. By number of funders, the Minuum Keyboard Project’s campaign is in Indiegogo’s top 10 of all time and is ranked No. 2 among all technology campaigns. Over 1.1 million people worldwide viewed Minuum’s original teaser video on YouTube, which the Whirlscape team edited and shot themselves.

Leave a comment

July 5, 2013 · 12:03 am



Weston adapter enables screen to mobile interaction.

Increase consumer engagement through dynamic mobile & motion technology while generating analytics for your digital advertisement.

​For a limited time test their tech and win prizes!

Enter their marketers contest to access their online platform. Create an engaging experience through photos, videos and NFC technology to win prizes! Upload, edit, organize, manage, and schedule your digital signage content in real-time online. Display your message at the perfect moment, to the perfect consumer.

Leave a comment

July 2, 2013 · 11:49 pm



Revolutionary Science

MYO lets you use the electrical activity in your muscles to wirelessly control your computer, phone, and other favorite digital technologies.

With a wave of your hand, MYO will transform how you interact with your digital world.


Leave a comment

July 2, 2013 · 11:37 pm

Drawn to Science

Leave a comment

June 18, 2013 · 6:53 pm



The myth is that Venture Capital VC is the primary source of startup funding, how ever figures show that VC financing is the exception not the norm, among start ups. Historically only a tiny percentage fewer that 1% of US companies have raised capital from VCs. Non VC sources of financing are growing rapidly and giving entrepreneurs many more choices than in the past. Angel investors, or wealthy individuals, who invest smaller amounts of capital at an earlier stage than VCs do – fund more than 16 times as many companies, and their share is growing. Number of VC firms fell from 744 to 526 in the decade 2001-2011.

In 2011 the capital raised was $19 billion, down from $39 billion in 2001, according to National Venture Capital Association NVCA, cited in HBR.org pp 81, May 2013. Today, alternative sources of funding is crowdfunding where by entrepreneurs raise small amounts of capital from large number of people in exchange of products or other rewards. Passage of the JOBS (jump-start our business startups) Act last year promises to support even faster growth by allowing crowdfunders to invest in exchange for equity and by expanding the pool of investors who can participate.

Kickstarter reports that more than 18000 projects raised nearly $320 million through its platform in 2012, which is three times more than the previous year. Kickstarter Website receives 9.9 million visits per month globally, which is  no doubt a contributing factor as to why so many of its projects get funding.

Angel shares in startups have shown growth of $ 22 billion in 65000 companies in 2011 – while in the same year, VCs invested in 3700 companies. AngelList online platform that connects startups with angel capital is one example.

Five deciding factors that hamper growth of startups are as follows:

1) high cost of getting the first customer and the product wrong

2) long technology development cycles

3)limited number of people with an appetite for the risks inherent in founding or working at a startup

4) structure of the venture capital industry, in which a small number of firms each needed to invest big sums in a handful of startups to have a chance at significant returns

5) the concentration of real expertise in how to build startups (Silicon Valley in US)

Source: Harvard business Review hbr.org, May 2013

1 Comment

June 17, 2013 · 7:47 pm

BDR Technologies

Diesel Reactor (BDR) Technologies is a clean energy technology company that provides innovative capital efficient process solutions to the multi-billion dollar global biodiesel industry.

The patented biodiesel membrane reactor offers a radical change in process operations and biodiesel product quality utilizing virgin oils, high FFA (free fatty acid) oils and next generation feedstocks.

BDR’s propriety membrane reactor system produces high quality biodiesel that surpasses the New ASTM Biodiesel No.1-B grade and the stringent quality specifications of major blenders while at the same time providing significant capital, operating and input cost savings to customers.


Leave a comment

June 10, 2013 · 12:49 am





IWatchLife records video only when events are detected so you don’t have to sort through hours of meaningless video to see what’s important.

Leave a comment

June 10, 2013 · 12:35 am


optelian 2home-bannbb

Leave a comment

June 9, 2013 · 11:48 pm

Epiphan Systems Inc.


epiphan-vga-grid-display-recorder-streamer-serverEpiphan Systems is a world leader in high resolution VGA, DVI and audio video capture, encoding, recording and streaming hardware. Backed by rock-solid customer support, our products allow you to capture, encode, record, stream and replay virtually any high­resolution video signal. Used extensively in a wide variety of areas including video re­cord­ing, medical imaging, webcasting and conference recording, Epiphan Systems’ products have received worldwide recognition from leading companies and organizations in the medical, secu­rity, education, transportation, industrial and IT fields

Used extensively in a wide variety of areas including video re­cord­ing, medical imaging, webcasting and conference recording, Epiphan Systems’ products have received worldwide recognition from leading companies and organizations in the medical, secu­rity, education, transportation, industrial and IT fields.

Leave a comment

June 9, 2013 · 11:41 pm

Solace Systems


Solace Systems, based in Ottawa, provides messaging middleware solutions that let companies efficiently distribute data to desktop, enterprise and mobile applications with higher performance and at lower cost than alternatives. The foundation of Solace’s solution is a turnkey appliance that’s available in two sizes to meet the needs of a wide range of businesses. Solace has been successfully deployed by customers in financial services, energy, government, internet services, telecom, transportation and logistics.


Leave a comment

June 9, 2013 · 11:34 pm



PERFUSIX is the world’s first and only commercial provider of ex-vivo organ perfusion services. PERFUSIX employs clinically proven ex-vivo organ perfusion technology and processes that restore and improve the function of donor organs. Most importantly, PERFUSIX increases the number of organs available for transplant, improves patient and organ survival, improves recipient quality of life, and reduces post-transplant care costs.

Leave a comment

June 6, 2013 · 1:59 pm


Leave a comment

June 1, 2013 · 4:19 pm

TearLab Osmolarity System

TearLab (NASDAQ:TEAR; TSX:TLB) has reported third quarter net revenues of $1.2-million, an increase of 264% from $333,000 for the same period in 2011, and up 69% sequentially from $716,000 in the second quarter this year.

TearLab Osmolarity System

Growing doctor interest in our technology and the significant role that it can play in the objective diagnoses and management of dry eye disease drove our strong revenue performance in what is historically a seasonally weaker third quarter in the eye care industry. A total of 92 orders for TearLab systems were booked in the period.  Of those, 77 were through the company’s access programs, 6 were direct purchases and 9 were purchased outside of the U.S.

Leave a comment

May 29, 2013 · 5:20 pm


Ostara Nutrient Recovery Technologies is a Canadian developer of solutions for recovering phosphorus and nitrogen from used water streams and transforming them into environmentally responsible, slow-release fertilizer. Ostara’s technology has applications in municipal wastewater treatment plants, biofuel processing plants, animal waste processing facilities, fertilizer producers and food & beverage processing plants.

Leave a comment



proxmifyThe fusion of content management and social networking that boosts productivity

Foster collaborations by mapping how individuals connect based on interests, skills, expertise and needs.

Reach out! Engage your community, disseminate results, attract the best amongst your target groups. http://www.proximify.ca/

Leave a comment

April 14, 2013 · 10:46 pm

Oxford Performance Materials


Oxford Performance Materials  OsteoFabTM Medical Devices and ImplantsReceives FDA approval.

Breaking the mold for the medical device market.

Utilizing the most advanced materials and technology, our OsteoFabTM process can reproduce exactly what you design, or exactly what nature intended by “printing” medical implants derived directly from a CT Scan or MRI file for a perfect anatomical fit with our own OXPEKK®-IG polymers.

However, this technology allows us to go beyond merely replicating shapes: we also have the ability to meet specific performance requirements as anatomically applicable. Through our proprietary “Coherent Implantology Process”, fit, form and bio-function are digitally calculated, constructed, and then produced. http://www.oxfordpm.com/biomedical_parts.html

Leave a comment

March 30, 2013 · 2:03 am



Wealthfront’s platform helps clients build and manage a diverse investment portfolio, rather than paying for an investment bank or private wealth manager. You put in the account type, amount to invest, and age, and this SEC-registered, software-based financial advisor will provide professional financial advise at a lower cost. The service also manages the personalized online investment account for you.



Leave a comment

March 27, 2013 · 3:42 pm



Prolucid LocalGrid Technologies is a spin-off by engineers from Prolucid Technologies with extensive software engineering experience; specializing in complex, mission critical embedded systems. This experience and our industry partnerships have allowed us to develop a Smart Grid ready platform that can be rapidly customized and deployed to the grid.

Leave a comment

March 27, 2013 · 3:32 pm

DLVR Therapeutics Inc


DLVR’s innovative technology is based on the synthesis and use of an HDL-mimetic phospholipid-based nanoparticle called HPPS (HDL-like Peptide-Phospholipid Scaffold).

DLVR Therapeutics Inc. is based in Toronto. Co-founded by University Health Network, the Ontario Institute for Cancer Research and MaRS Innovation, the Company is developing an innovative, HDL-like Peptide-Phospholipid Scaffold (HPPS) nanoparticle delivery system. HPPS enhances cell targeting and bypasses endosomal degradation, two common problems which beset contemporary delivery systems. Mechanistically, HPPS appropriates HDL’s affinity for its natural ligand, Scavenger Receptor B1 (SR-B1) to preferentially target this receptor.  Upregulated in many solid tumors such as breast, colorectal, pancreatic and ovarian, SR-B1 facilitates direct delivery of payload to the cytosol of tumor cells. The ultra-small HPPS particle is suitable for a variety of different RNAi payloads. The company’s development strategy is to collaborate with partners that have developed novel RNAi therapeutics that require an innovative delivery technology.


Read More

Leave a comment

March 19, 2013 · 6:45 pm



The best way for high school students and their families to manage the financial aid process from start to finish.


Leave a comment

March 19, 2013 · 5:10 pm

NPS pharma

npsNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide.

Gattex_logoThe company’s lead product, Gattex® 0.05 mg/kg/d (Teduglutide [rDNA origin]) for Injection for subcutaneous use is FDA-approved for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support. NPS is also developing Natpara® (rhPTH[1-84]) for the treatment of adult hypoparathyroidism and expects to submit its Biologic License Application (BLA) to the FDA in mid-2013. NPS’s earlier stage pipeline includes two calcilytic compounds, NPSP790 and NPSP795, with potential application in rare disorders involving increased calcium receptor activity, such as autosomal dominant hypocalcemia with hypercalciuria (ADHH). NPS complements its proprietary programs with a royalty-based portfolio of products and product candidates.

Leave a comment

March 17, 2013 · 7:18 pm




COMMUNITECH provides expertise and resources to startup companies, engaging executive-level talent from the Region. With more than 30 monthly groups,  COMMUNITECH Peer2Peer network sees over 2,500 monthly attendees. This network gives their members an opportunity to plug into sessions with people in similar roles to explore common challenges, and exchange advice.

Leave a comment

March 14, 2013 · 5:52 pm



Venturelynx is sophisticated security and permissions system control who sees each news post, file or piece of data.

Entrepreneurs can take control of network, use best practices, raise funds easily.
Investors stay informed on investments and speed up due diligence.
Lawyers and Accountants focus on high value work, not searching for files.http://www.venturelynx.com

Leave a comment

March 13, 2013 · 8:41 pm